AbCellera Biologics (ABCL) P/E (2020 - 2026)
AbCellera Biologics (ABCL) P/E from Dec 11, 2020 to Jul 20, 2026. The TTM AbCellera Biologics (ABCL) P/E is -12.08. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of AbCellera Biologics (ABCL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -12.08 | +73.92% |
| 2025 | -6.94 | +32.03% |
| 2024 | -5.26 | -58.58% |
| 2023 | -12.70 | -209.50% |
| 2022 | 11.60 | -54.59% |
| 2021 | 25.54 | -71.64% |
| 2020 | 90.07 | N/A |
Comparison AbCellera Biologics (ABCL) P/E with competitors
AbCellera Biologics (ABCL) P/E is -12.08.